Total Funding
26
50
Total FundingCorporate Round raised
Growth Score
-5 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
91594
Dianomi Therapeutics company focused on developing treatments for inflammatory diseases, initially targeting osteoarthritis (OA).
- William L. Murphy: CSO and Co-Founder
- Barry Kurokawa: CEO and Co-Founder
About the Company
Dianomi Therapeutics is a development stage biopharmaceutical company focused on improving the delivery and efficacy of large and small molecules in the treatment of inflammatory diseases. With an initial focus on osteoarthritis and rheumatoid arthritis, They are working to enhance the safety, efficacy, and duration of effect of therapeutic agents
by incorporating them with Thier proprietary mineral coated microparticle system (MCM).
Women Founded
